However, there was significantly robust expression of ANGPT2 in tumor vessels in the refractory Bev group (24.36/5 HPF) compared with that in the naïve (8.68/5 HPF) and effective (9.60/5 HPF) Bev groups. The gene discussed is ANGPT2; the disease is neoplasm.